Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins

Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins

Currently, chondroitin sulfate (CS) and hyaluronic acid (HA) pharma-grade forms are used for osteoarthritis (OA) management, CS as an oral formulations component, and HA as intra-articular injective medical devices. Recently, unsulfated chondroitin, obtained through biofermentative (BC) manufacturin...

Full description

Bibliographic Details
Main Authors: Valentina Vassallo, Celeste Di Meo, Giuseppe Toro, Alberto Alfano, Giovanni Iolascon, Chiara Schiraldi
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceuticals
Subjects:
hyaluronic acid
biofermentative chondroitin
articular cartilage
human primary pathological chondrocytes
osteoarthritis
Online Access:https://www.mdpi.com/1424-8247/16/10/1429

Internet

https://www.mdpi.com/1424-8247/16/10/1429

Similar Items